| 國立臺灣大學 |
2008-01 |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Wu, YW; Yang, WS; Chen, MF; Lee, BC; Hung, CS; Liu, YC; Jeng, JS; Huang, PJ; Kao, HL. |
| 國立臺灣大學 |
2008 |
High Serum Level of Matrix Metalloproteinase-1 and Its Rapid Surge after Intervention in Patients with Significant Carotid Atherosclerosis
|
吳彥雯; 楊偉勛; 陳明豐; 李百卿; 洪啟盛; 鄭建興; 黃博昭; 高憲立; WU, YEN-WEN; YANG, WEI-SHIUNG; CHEN, MING-FONG; LEE, BAI-CHING; HUNG, CHI-SHENG; JENG, JIANN-SHING; HUANG, POR-JAU; KAO, HSIEN-LI |
| 臺大學術典藏 |
2018-09-10T06:51:54Z |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Wu, YW;Yang, WS;Chen, MF;Lee, BC;Hung, CS;Liu, YC;Jeng, JS;Huang, PJ;Kao, HL.; Wu, Y.-W. and Yang, W.-S. and Chen, M.-F. and Lee, B.-C. and Hung, C.-S. and Liu, Y.-C. and Jeng, J.-S. and Huang, P.-J. and Kao, H.-L.; Wu, YW; JIANN-SHING JENG; HSIEN-LI KAO; Yang, WS; Chen, MF; WEI-SHIUNG YANG; BAI-CHIN LEE; Lee, BC; YEN-WEN WU; Hung, CS; Liu, YC; Jeng, JS; Huang, PJ; Kao, HL. |
| 臺大學術典藏 |
2020-03-03T03:46:02Z |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Liu Y.-C.; JIANN-SHING JENG; Huang P.-J.; Kao H.-L.; Wu Y.-W.; Yang W.-S.; Chen M.-F.; Lee B.-C.; Hung C.-S. |
| 臺大學術典藏 |
2020-11-03T11:45:10Z |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Kao H.-L.; Wu Y.-W.; Yang W.-S.; Chen M.-F.; Lee B.-C.; Hung C.-S.; Liu Y.-C.; JIANN-SHING JENG; Huang P.-J. |
| 臺大學術典藏 |
2020-12-03T06:05:27Z |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Wu Y.-W.; Yang W.-S.; Chen M.-F.; BAI-CHIN LEE; Hung C.-S.; Liu Y.-C.; Jeng J.-S.; Huang P.-J.; Kao H.-L. |
| 臺大學術典藏 |
2008 |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Wu Y.-W.; HSIEN-LI KAO; Huang P.-J.; Jeng J.-S.; Yang W.-S.; Chen M.-F.; Lee B.-C.; Hung C.-S.; Liu Y.-C. |
| 臺大學術典藏 |
2008 |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
HSIEN-LI KAO; Huang P.-J.; Jeng J.-S.; Liu Y.-C.; Hung C.-S.; Wu Y.-W.; Yang W.-S.; Chen M.-F.; Lee B.-C. |
| 臺大學術典藏 |
2021-07-02T02:35:54Z |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Wu Y.-W.; WEI-SHIUNG YANG; Chen M.-F.; Lee B.-C.; Hung C.-S.; Liu Y.-C.; Jeng J.-S.; Huang P.-J.; Kao H.-L. |
| 臺大學術典藏 |
2021-12-22T03:54:34Z |
High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis
|
Wu Y.-W.; Yang W.-S.; Chen M.-F.; Lee B.-C.; Hung C.-S.; Liu Y.-C.; JIANN-SHING JENG; Huang P.-J.; Kao H.-L. |
| 國立臺灣大學 |
2014 |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Huang, Chun-Ta; Lee, Li-Na; Ho, Chao-Chi; Shu, Chin-Chung; Ruan, Sheng-Yuan; Tsai, Yi-Ju; Wang, Jann-Yuan; Yu, Chong-Jen; 李麗娜; 余忠仁; 樹金忠; 何肇基; 阮聖元; 王振源; 黃俊達 |
| 臺大學術典藏 |
2018-09-10T14:49:26Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Huang, Chun-Ta;Lee, Li-Na;Ho, Chao-Chi;Shu, Chin-Chung;Ruan, Sheng-Yuan;Tsai, Yi-Ju;Wang, Jann-Yuan;Yu, Chong-Jen; Huang, C.-T. and Lee, L.-N. and Ho, C.-C. and Shu, C.-C. and Ruan, S.-Y. and Tsai, Y.-J. and Wang, J.-Y. and Yu, C.-J.; 李麗娜;余忠仁;樹金忠;何肇基;阮聖元;王振源;黃俊達; 李麗娜;余忠仁;樹金忠;何肇基;阮聖元;王振源;黃俊達; Huang, Chun-Ta; CHIN-CHUNG SHU; Huang, Chun-Ta; Lee, Li-Na; Lee, Li-Na; CHUN-TA HUANG; Ho, Chao-Chi; SHENG-YUAN RUAN; Ho, Chao-Chi; LI-NA LEE; Shu, Chin-Chung; Shu, Chin-Chung; Ruan, Sheng-Yuan; Ruan, Sheng-Yuan; Chong-Jen Yu; JANN-YUAN WANG; Tsai, Yi-Ju; Tsai, Yi-Ju; CHAO-CHI HO; Wang, Jann-Yuan; Wang, Jann-Yuan; Yu, Chong-Jen; Yu, Chong-Jen |
| 臺大學術典藏 |
2020-03-31T08:54:32Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Shu C.-C.; Ho C.-C.; LI-NA LEE; Huang C.-T.; Ruan S.-Y.; Tsai Y.-J.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:28Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Tsai Y.-J.; Wang J.-Y.; Yu C.-J.; Huang C.-T.; Lee L.-N.; CHAO-CHI HO; Shu C.-C.; Ruan S.-Y. |
| 臺大學術典藏 |
2020-08-12T07:57:20Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Huang C.-T.; Lee L.-N.; Ho C.-C.; Shu C.-C.; SHENG-YUAN RUAN; Tsai Y.-J.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T05:24:15Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Yu C.-J.; JANN-YUAN WANG; Huang C.-T.; Lee L.-N.; Ho C.-C.; Shu C.-C.; Ruan S.-Y.; Tsai Y.-J. |
| 臺大學術典藏 |
2021-06-29T06:28:24Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
CHUN-TA HUANG; Lee L.-N.; Ho C.-C.; Shu C.-C.; Ruan S.-Y.; Tsai Y.-J.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-06-29T08:39:20Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Huang C.-T.; Lee L.-N.; Ho C.-C.; CHIN-CHUNG SHU; Ruan S.-Y.; Tsai Y.-J.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-03-12T02:28:32Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Huang C.-T.; LI-NA LEE; Ho C.-C.; Shu C.-C.; Ruan S.-Y.; Tsai Y.-J.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2022-06-27T07:01:52Z |
High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis
|
Huang C.-T.; Lee L.-N.; Ho C.-C.; Shu C.-C.; Ruan S.-Y.; Tsai Y.-J.; Wang J.-Y.; CHONG-JEN YU |
| 國立臺灣大學 |
2014 |
High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-beta 1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy
|
Cheng, Jason Chia-Hsien; Graber, Madeline S.; Hsu, Feng-Ming; Tsai, Chiao-Ling; Castaneda, Leon; Lee, Jang-Ming; Chang, Daniel T.; Koong, Albert C.; 成佳憲; 李章銘; 蔡巧琳; 許峰銘 |
| 臺大學術典藏 |
2018-09-10T14:53:14Z |
High serum levels of vascular endothelial growth Factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy
|
Cheng, Jason Chia-Hsien;Graber, Madeline S.;Hsu, Feng-Ming;Tsai, Chiao-Ling;Castaneda, Leon;Lee, Jang-Ming;Chang, Daniel T.;Koong, Albert C.; Cheng, J.C.-H. and Graber, M.S. and Hsu, F.-M. and Tsai, C.-L. and Castaneda, L. and Lee, J.-M. and Chang, D.T. and Koong, A.C.; 成佳憲;李章銘;蔡巧琳;許峰銘; 成佳憲; Cheng, Jason Chia-Hsien; JANG-MING LEE; Ahn, Hyun-Soo; Graber, Madeline S.; Hsu, Feng-Ming; Tsai, Chiao-Ling; Castaneda, Leon; Lee, Jang-Ming; Chang, Daniel T.; Koong, Albert C. |
| 臺大學術典藏 |
2014 |
High serum levels of vascular endothelial growth Factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy
|
Cheng J.C.-H.;Graber M.S.;Hsu F.-M.;Tsai C.-L.;Castaneda L.;Jang-Ming Lee;Chang D.T.;Koong A.C.; Cheng J.C.-H.; Graber M.S.; Hsu F.-M.; Tsai C.-L.; Castaneda L.; JANG-MING LEE; Chang D.T.; Koong A.C. |
| 臺大學術典藏 |
2020-05-25T02:45:38Z |
High serum levels of vascular endothelial growth Factor-A and transforming growth factor-�]1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy
|
Graber M.S; Feng-Ming Hsu; Tsai C.-L; Castaneda L; Lee J.-M; Chang D.T; Koong A.C.; Cheng J.C.-H |
| 臺大學術典藏 |
2021-05-21T07:17:48Z |
High serum levels of vascular endothelial growth Factor-A and transforming growth factor-�]1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy
|
Cheng J.C.-H.; Graber M.S.; Hsu F.-M.; CHIAO-LING TSAI; Castaneda L.; Lee J.-M.; Chang D.T.; Koong A.C. |
